 | • レポートコード：GIR-107A14627 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、カンジダ症治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。カンジダ症治療薬の種類別市場規模（ドキソルビシン、シスプラチン、7カルボプラチン、エトポシド、イホスファミド、シクロホスファミド、メトトレキサート、ビンクリスチン）、用途別市場規模（多専門病院、がん研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・カンジダ症治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis AG、Amgen、F. Hoffmann-La Roche Ltd.、Bayer-Algeta、Merrion Pharmaceuticals Plc.、Ablynx、Genta Incorporated、Galapagos NV、Catena Pharmaceuticals Inc.、Digna Biotech S.L.、Medivir AB、Amura Holdings ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ドキソルビシン、シスプラチン、7カルボプラチン、エトポシド、イホスファミド、シクロホスファミド、メトトレキサート、ビンクリスチン ・用途別分析2016年-2026年：多専門病院、がん研究機関、その他 ・カンジダ症治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・カンジダ症治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・カンジダ症治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・カンジダ症治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・カンジダ症治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Candidiasis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Candidiasis Therapeutics size is estimated to be xx million in 2021 from USD 3095.1 million in 2020, with a change of XX% between 2020 and 2021. The global Candidiasis Therapeutics market size is expected to grow at a CAGR of 3.1% for the next five years.
Market segmentation
Candidiasis Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Doxorubicin
Cisplatin
7Carboplatin
Etoposide
Ifosfamide
Cyclophosphamide
Methotrexate
Vincristine
Market segment by Application can be divided into
Multispecialty Hospitals
Cancer Research Institutes
Others
The key market players for global Candidiasis Therapeutics market are listed below:
Novartis AG
Amgen
F. Hoffmann-La Roche Ltd.
Bayer-Algeta
Merrion Pharmaceuticals Plc.
Ablynx
Genta Incorporated
Galapagos NV
Catena Pharmaceuticals Inc.
Digna Biotech S.L.
Medivir AB
Amura Holdings
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Candidiasis Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Candidiasis Therapeutics, with price, sales, revenue and global market share of Candidiasis Therapeutics from 2019 to 2021.
Chapter 3, the Candidiasis Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Candidiasis Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Candidiasis Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Candidiasis Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Candidiasis Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Candidiasis Therapeutics Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Doxorubicin
1.2.3 Cisplatin
1.2.4 7Carboplatin
1.2.5 Etoposide
1.2.6 Ifosfamide
1.2.7 Cyclophosphamide
1.2.8 Methotrexate
1.2.9 Vincristine
1.3 Market Analysis by Application
1.3.1 Overview: Global Candidiasis Therapeutics Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Multispecialty Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Others
1.4 Global Candidiasis Therapeutics Market Size & Forecast
1.4.1 Global Candidiasis Therapeutics Sales in Value (2016-2026))
1.4.2 Global Candidiasis Therapeutics Sales in Volume (2016-2026)
1.4.3 Global Candidiasis Therapeutics Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Candidiasis Therapeutics Production Capacity Analysis
1.5.1 Global Candidiasis Therapeutics Total Production Capacity (2016-2026)
1.5.2 Global Candidiasis Therapeutics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Candidiasis Therapeutics Market Drivers
1.6.2 Candidiasis Therapeutics Market Restraints
1.6.3 Candidiasis Therapeutics Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Candidiasis Therapeutics Product and Services
2.1.4 Novartis AG Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Candidiasis Therapeutics Product and Services
2.2.4 Amgen Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business
2.3.3 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product and Services
2.3.4 F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bayer-Algeta
2.4.1 Bayer-Algeta Details
2.4.2 Bayer-Algeta Major Business
2.4.3 Bayer-Algeta Candidiasis Therapeutics Product and Services
2.4.4 Bayer-Algeta Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Merrion Pharmaceuticals Plc.
2.5.1 Merrion Pharmaceuticals Plc. Details
2.5.2 Merrion Pharmaceuticals Plc. Major Business
2.5.3 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product and Services
2.5.4 Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Ablynx
2.6.1 Ablynx Details
2.6.2 Ablynx Major Business
2.6.3 Ablynx Candidiasis Therapeutics Product and Services
2.6.4 Ablynx Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Genta Incorporated
2.7.1 Genta Incorporated Details
2.7.2 Genta Incorporated Major Business
2.7.3 Genta Incorporated Candidiasis Therapeutics Product and Services
2.7.4 Genta Incorporated Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Galapagos NV
2.8.1 Galapagos NV Details
2.8.2 Galapagos NV Major Business
2.8.3 Galapagos NV Candidiasis Therapeutics Product and Services
2.8.4 Galapagos NV Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Catena Pharmaceuticals Inc.
2.9.1 Catena Pharmaceuticals Inc. Details
2.9.2 Catena Pharmaceuticals Inc. Major Business
2.9.3 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product and Services
2.9.4 Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Digna Biotech S.L.
2.10.1 Digna Biotech S.L. Details
2.10.2 Digna Biotech S.L. Major Business
2.10.3 Digna Biotech S.L. Candidiasis Therapeutics Product and Services
2.10.4 Digna Biotech S.L. Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Medivir AB
2.11.1 Medivir AB Details
2.11.2 Medivir AB Major Business
2.11.3 Medivir AB Candidiasis Therapeutics Product and Services
2.11.4 Medivir AB Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Amura Holdings
2.12.1 Amura Holdings Details
2.12.2 Amura Holdings Major Business
2.12.3 Amura Holdings Candidiasis Therapeutics Product and Services
2.12.4 Amura Holdings Candidiasis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Candidiasis Therapeutics Sales by Manufacturer
3.1 Global Candidiasis Therapeutics Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Candidiasis Therapeutics Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Candidiasis Therapeutics
3.4 Market Concentration Rate
3.4.1 Top 3 Candidiasis Therapeutics Manufacturer Market Share
3.4.2 Top 6 Candidiasis Therapeutics Manufacturer Market Share
3.5 Global Candidiasis Therapeutics Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Candidiasis Therapeutics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Candidiasis Therapeutics Market Size by Region
4.1.1 Global Candidiasis Therapeutics Sales in Volume by Region (2016-2026)
4.1.2 Global Candidiasis Therapeutics Revenue by Region (2016-2026)
4.2 North America Candidiasis Therapeutics Revenue (2016-2026)
4.3 Europe Candidiasis Therapeutics Revenue (2016-2026)
4.4 Asia-Pacific Candidiasis Therapeutics Revenue (2016-2026)
4.5 South America Candidiasis Therapeutics Revenue (2016-2026)
4.6 Middle East and Africa Candidiasis Therapeutics Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Candidiasis Therapeutics Sales in Volume by Type (2016-2026)
5.2 Global Candidiasis Therapeutics Revenue by Type (2016-2026)
5.3 Global Candidiasis Therapeutics Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Candidiasis Therapeutics Sales in Volume by Application (2016-2026)
6.2 Global Candidiasis Therapeutics Revenue by Application (2016-2026)
6.3 Global Candidiasis Therapeutics Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Candidiasis Therapeutics Sales by Type (2016-2026)
7.2 North America Candidiasis Therapeutics Sales by Application (2016-2026)
7.3 North America Candidiasis Therapeutics Market Size by Country
7.3.1 North America Candidiasis Therapeutics Sales in Volume by Country (2016-2026)
7.3.2 North America Candidiasis Therapeutics Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Candidiasis Therapeutics Sales by Type (2016-2026)
8.2 Europe Candidiasis Therapeutics Sales by Application (2016-2026)
8.3 Europe Candidiasis Therapeutics Market Size by Country
8.3.1 Europe Candidiasis Therapeutics Sales in Volume by Country (2016-2026)
8.3.2 Europe Candidiasis Therapeutics Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Candidiasis Therapeutics Sales by Type (2016-2026)
9.2 Asia-Pacific Candidiasis Therapeutics Sales by Application (2016-2026)
9.3 Asia-Pacific Candidiasis Therapeutics Market Size by Region
9.3.1 Asia-Pacific Candidiasis Therapeutics Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Candidiasis Therapeutics Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Candidiasis Therapeutics Sales by Type (2016-2026)
10.2 South America Candidiasis Therapeutics Sales by Application (2016-2026)
10.3 South America Candidiasis Therapeutics Market Size by Country
10.3.1 South America Candidiasis Therapeutics Sales in Volume by Country (2016-2026)
10.3.2 South America Candidiasis Therapeutics Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Candidiasis Therapeutics Sales by Type (2016-2026)
11.2 Middle East & Africa Candidiasis Therapeutics Sales by Application (2016-2026)
11.3 Middle East & Africa Candidiasis Therapeutics Market Size by Country
11.3.1 Middle East & Africa Candidiasis Therapeutics Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Candidiasis Therapeutics Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Candidiasis Therapeutics Typical Distributors
12.3 Candidiasis Therapeutics Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Candidiasis Therapeutics Revenue by Type, (USD Million), 2021-2026
Table 2. Global Candidiasis Therapeutics Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Candidiasis Therapeutics Product and Services
Table 6. Novartis AG Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amgen Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Major Business
Table 9. Amgen Candidiasis Therapeutics Product and Services
Table 10. Amgen Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 12. F. Hoffmann-La Roche Ltd. Major Business
Table 13. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Product and Services
Table 14. F. Hoffmann-La Roche Ltd. Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer-Algeta Basic Information, Manufacturing Base and Competitors
Table 16. Bayer-Algeta Major Business
Table 17. Bayer-Algeta Candidiasis Therapeutics Product and Services
Table 18. Bayer-Algeta Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Merrion Pharmaceuticals Plc. Basic Information, Manufacturing Base and Competitors
Table 20. Merrion Pharmaceuticals Plc. Major Business
Table 21. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Product and Services
Table 22. Merrion Pharmaceuticals Plc. Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Ablynx Basic Information, Manufacturing Base and Competitors
Table 24. Ablynx Major Business
Table 25. Ablynx Candidiasis Therapeutics Product and Services
Table 26. Ablynx Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Genta Incorporated Basic Information, Manufacturing Base and Competitors
Table 28. Genta Incorporated Major Business
Table 29. Genta Incorporated Candidiasis Therapeutics Product and Services
Table 30. Genta Incorporated Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Galapagos NV Basic Information, Manufacturing Base and Competitors
Table 32. Galapagos NV Major Business
Table 33. Galapagos NV Candidiasis Therapeutics Product and Services
Table 34. Galapagos NV Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Catena Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Catena Pharmaceuticals Inc. Major Business
Table 37. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Product and Services
Table 38. Catena Pharmaceuticals Inc. Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Digna Biotech S.L. Basic Information, Manufacturing Base and Competitors
Table 40. Digna Biotech S.L. Major Business
Table 41. Digna Biotech S.L. Candidiasis Therapeutics Product and Services
Table 42. Digna Biotech S.L. Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Medivir AB Basic Information, Manufacturing Base and Competitors
Table 44. Medivir AB Major Business
Table 45. Medivir AB Candidiasis Therapeutics Product and Services
Table 46. Medivir AB Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Amura Holdings Basic Information, Manufacturing Base and Competitors
Table 48. Amura Holdings Major Business
Table 49. Amura Holdings Candidiasis Therapeutics Product and Services
Table 50. Amura Holdings Candidiasis Therapeutics Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Candidiasis Therapeutics Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 52. Global Candidiasis Therapeutics Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Candidiasis Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Candidiasis Therapeutics Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 55. Head Office and Candidiasis Therapeutics Production Site of Key Manufacturer
Table 56. Candidiasis Therapeutics New Entrant and Capacity Expansion Plans
Table 57. Candidiasis Therapeutics Mergers & Acquisitions in the Past Five Years
Table 58. Global Candidiasis Therapeutics Sales by Region (2016-2021e) & (K Pcs)
Table 59. Global Candidiasis Therapeutics Sales by Region (2021-2026) & (K Pcs)
Table 60. Global Candidiasis Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Candidiasis Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Candidiasis Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 63. Global Candidiasis Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 64. Global Candidiasis Therapeutics Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Candidiasis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Candidiasis Therapeutics Price by Type (2016-2021e) & (USD/Pcs)
Table 67. Global Candidiasis Therapeutics Price by Type (2021-2026) & (USD/Pcs)
Table 68. Global Candidiasis Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 69. Global Candidiasis Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 70. Global Candidiasis Therapeutics Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Candidiasis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Candidiasis Therapeutics Price by Application (2016-2021e) & (USD/Pcs)
Table 73. Global Candidiasis Therapeutics Price by Application (2021-2026) & (USD/Pcs)
Table 74. North America Candidiasis Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 75. North America Candidiasis Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 76. North America Candidiasis Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Candidiasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Candidiasis Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 79. North America Candidiasis Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 80. North America Candidiasis Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 81. North America Candidiasis Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 82. Europe Candidiasis Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 83. Europe Candidiasis Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 84. Europe Candidiasis Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Candidiasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Candidiasis Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 87. Europe Candidiasis Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 88. Europe Candidiasis Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 89. Europe Candidiasis Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 90. Asia-Pacific Candidiasis Therapeutics Sales by Region (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Candidiasis Therapeutics Sales by Region (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Candidiasis Therapeutics Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Candidiasis Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Candidiasis Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 95. Asia-Pacific Candidiasis Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 96. Asia-Pacific Candidiasis Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 97. Asia-Pacific Candidiasis Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 98. South America Candidiasis Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 99. South America Candidiasis Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 100. South America Candidiasis Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Candidiasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Candidiasis Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 103. South America Candidiasis Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 104. South America Candidiasis Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 105. South America Candidiasis Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 106. Middle East & Africa Candidiasis Therapeutics Sales by Country (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Candidiasis Therapeutics Sales by Country (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Candidiasis Therapeutics Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Candidiasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Candidiasis Therapeutics Sales by Type (2016-2021e) & (K Pcs)
Table 111. Middle East & Africa Candidiasis Therapeutics Sales by Type (2021-2026) & (K Pcs)
Table 112. Middle East & Africa Candidiasis Therapeutics Sales by Application (2016-2021e) & (K Pcs)
Table 113. Middle East & Africa Candidiasis Therapeutics Sales by Application (2021-2026) & (K Pcs)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Candidiasis Therapeutics Typical Distributors
Table 117. Candidiasis Therapeutics Typical Customers
List of Figures
Figure 1. Candidiasis Therapeutics Picture
Figure 2. Global Candidiasis Therapeutics Sales Market Share by Type in 2020
Figure 3. Doxorubicin
Figure 4. Cisplatin
Figure 5. 7Carboplatin
Figure 6. Etoposide
Figure 7. Ifosfamide
Figure 8. Cyclophosphamide
Figure 9. Methotrexate
Figure 10. Vincristine
Figure 11. Global Candidiasis Therapeutics Sales Market Share by Application in 2020
Figure 12. Multispecialty Hospitals
Figure 13. Cancer Research Institutes
Figure 14. Others
Figure 15. Global Candidiasis Therapeutics Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global Candidiasis Therapeutics Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Candidiasis Therapeutics Sales (2016-2026) & (K Pcs)
Figure 18. Global Candidiasis Therapeutics Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global Candidiasis Therapeutics Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global Candidiasis Therapeutics Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Candidiasis Therapeutics Market Drivers
Figure 22. Candidiasis Therapeutics Market Restraints
Figure 23. Candidiasis Therapeutics Market Trends
Figure 24. Global Candidiasis Therapeutics Sales Market Share by Manufacturer in 2020
Figure 25. Global Candidiasis Therapeutics Revenue Market Share by Manufacturer in 2020
Figure 26. Candidiasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Candidiasis Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Candidiasis Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Candidiasis Therapeutics Sales Market Share by Region (2016-2026)
Figure 30. Global Candidiasis Therapeutics Revenue Market Share by Region (2016-2026)
Figure 31. North America Candidiasis Therapeutics Revenue (2016-2026) & (USD Million)
Figure 32. Europe Candidiasis Therapeutics Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Candidiasis Therapeutics Revenue (2016-2026) & (USD Million)
Figure 34. South America Candidiasis Therapeutics Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Candidiasis Therapeutics Revenue (2016-2026) & (USD Million)
Figure 36. Global Candidiasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 37. Global Candidiasis Therapeutics Revenue Market Share by Type (2016-2026)
Figure 38. Global Candidiasis Therapeutics Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global Candidiasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 40. Global Candidiasis Therapeutics Revenue Market Share by Application (2016-2026)
Figure 41. Global Candidiasis Therapeutics Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America Candidiasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 43. North America Candidiasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 44. North America Candidiasis Therapeutics Sales Market Share by Country (2016-2026)
Figure 45. North America Candidiasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 46. United States Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Candidiasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 50. Europe Candidiasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 51. Europe Candidiasis Therapeutics Sales Market Share by Country (2016-2026)
Figure 52. Europe Candidiasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 53. Germany Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Candidiasis Therapeutics Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Candidiasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Candidiasis Therapeutics Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Candidiasis Therapeutics Revenue Market Share by Region (2016-2026)
Figure 62. China Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Candidiasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 69. South America Candidiasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 70. South America Candidiasis Therapeutics Sales Market Share by Country (2016-2026)
Figure 71. South America Candidiasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Candidiasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Candidiasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Candidiasis Therapeutics Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Candidiasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Candidiasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界の特発性血小板減少性紫斑病（ITP）治療市場 2021：企業別、地域別、種類・用途別 The Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…- 世界の性感染症治療市場 2021：企業別、地域別、種類・用途別 The Sexually Transmitted Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の糖鎖生物学（診断・治療）市場 2021：企業別、地域別、種類・用途別 The Glycobiology (Diagnostics and Therapeutics) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 世界の網膜疾患治療市場 2021：企業別、地域別、種類・用途別 The Retinal Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の未熟児網膜症治療市場 2021：企業別、地域別、種類・用途別 The Retinopathy Of Prematurity Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…